Benedicte Callan is a Clinical Professor at Arizona State University’s School of Public Affairs and School for the Future of Innovation in Society. Dr. Callan’s interests focus on how new technologies challenge existing institutional structures and business models and how different political movements seek to influence the direction or rate of change that new technologies enable. Currently, Dr. Callan is working on the politics of disinformation in the life sciences, the deregulation of biopharmaceutical innovation during crises like Covid-19, the challenge of regulating germline gene editing on a global scale, and the politics of health privacy in an era when both patients and industry want access to PHI. Prior to ASU, Dr. Callan was the Sid Richardson Fellow and Lecturer at the LBJ School of Public Affairs at the University of Texas, Austin. From 1998-2009 she was an Administrator at the Organization of Economic Cooperation and Development in Paris, France, serving in a variety of positions including as Head of the Biotechnology Unit and as Executive Assistant to the Deputy Secretary-General. She has been a lecturer at Princeton University, a Fellow for the Center for Information Technology and Policy at Princeton University, and a Fellow for Political Economy at the Council on Foreign Relations in New York. Dr. Callan got her PhD at UC Berkeley in Political Science and her BA from Yale University in Biology & East Asian Studies.